Regulation of interleukin-4 activity by soluble interleukin-4 receptors.
Enssle
K
K
Research Laboratories Behringwerke AG, Marburg, Germany.
Schulz
G
G
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy; D007239:Infections / Q000276:immunology / Q000628:therapy; D015847:Interleukin-4 / Q000378:metabolism*; D018123:Receptors, Interleukin / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D019948:Receptors, Interleukin-4; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D012995:Solubility; D018418:Th2 Cells / Q000276:immunology
D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D018123:Receptors, Interleukin; D019948:Receptors, Interleukin-4; D011993:Recombinant Fusion Proteins; D015847:Interleukin-4